| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 1997;30:209-216.)
© 1997 American Heart Association, Inc.
Articles |
Angiotensin II and Myocyte Growth
Role of Fibroblasts
From the Department of Molecular Cardiology, Research Institute, The Cleveland Clinic Foundation (Ohio).
Correspondence to Subha Sen, PhD, DSc, Department of Molecular Cardiology/FF40, Research Institute, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195. E-mail sens{at}cesmtp.ccf.org
Abstract Angiotensin II (Ang II) has been implicated in stimulating myocyte growth in vitro, but the mechanism for such stimulation is still an open question. To understand the role of Ang II, we studied its effect on protein synthesis in rat neonatal and adult myocytes. Ang II (10-8 mol/L) stimulated protein synthesis in neonatal myocytes by 43±3.5% over control. To prevent the proliferation of fibroblasts, bromodeoxyuridine was added, and protein synthesis in neonatal myocytes was reduced to 21±2.2% over control. In adult myocytes (cultured without bromodeoxyuridine), Ang II stimulated [3H]leucine incorporation by 24±2.3% over control; with bromodeoxyuridine, that stimulation was reduced significantly (13±0.93% over control). These data suggest that the presence of fibroblasts in the cultures may control myocyte growth. When supernatant from pure fibroblast culture was added to myocyte preparations, a significant increase (49.8±3.5% over control) in protein synthesis occurred. Pretreatment of these fibroblasts with Ang II (10-8 mol/L) further stimulated protein synthesis, suggesting that Ang II directly stimulates the production of a factor from fibroblasts. The stimulatory effect of Ang II on the release of the factor can be completely blocked by pretreatment with losartan, an Ang II receptor (AT1) blocker. Our data are the first to demonstrate a paracrine effect of a fibroblast-derived factor that modulates myocyte growth. Fibroblast-derived factor loses its biological activity by (1) tryptic digestion, (2) exposure to pH below 4.0 and above 9.0, and (3) heating to 95°C. The molecular weight of the factor is approximately 65 kD. The antibodies against fibroblast growth factor (both acidic and basic) could not inhibit this factor's stimulatory effect. Furthermore, this factor is heart specific and is produced at least up to the 16th passage of neonatal rat heart fibroblasts. Skin fibroblasts, aortic endothelial cells, and aortic smooth muscle cells do not produce this protein. Our data suggest that the observed myocyte growth by Ang II comes about via fibroblast-derived factor, which is increased by Ang II. Cross talk between fibroblasts and myocytes is an important factor in stimulating myocyte growth by Ang II.
Key Words: fibroblast-derived factor • angiotensin II • fibroblasts • myocyte growth
This article has been cited by other articles:
 |
|
 |
|
  S. P. Jones and S. W. Kennedy Chicken Embryo Cardiomyocyte Cultures--A New Approach for Studying Effects of Halogenated Aromatic Hydrocarbons in the Avian Heart Toxicol. Sci., May 1, 2009; 109(1): 66 - 74. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Camelliti, T. K. Borg, and P. Kohl Structural and functional characterisation of cardiac fibroblasts Cardiovasc Res, January 1, 2005; 65(1): 40 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Sarkar, E. Vellaichamy, D. Young, and S. Sen Influence of cytokines and growth factors in ANG II-mediated collagen upregulation by fibroblasts in rats: role of myocytes Am J Physiol Heart Circ Physiol, July 1, 2004; 287(1): H107 - H117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G. Perez, M. C. C. de Hurtado, and H. E. Cingolani Reverse Mode of the Na+-Ca2+ Exchange After Myocardial Stretch : Underlying Mechanism of the Slow Force Response Circ. Res., March 2, 2001; 88(4): 376 - 382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Saint-Marc, L. P. Kozak, G. Ailhaud, C. Darimont, and R. Negrel Angiotensin II as a Trophic Factor of White Adipose Tissue: Stimulation of Adipose Cell Formation Endocrinology, January 1, 2001; 142(1): 487 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Engeli, R. Negrel, and A. M. Sharma Physiology and Pathophysiology of the Adipose Tissue Renin-Angiotensin System Hypertension, June 1, 2000; 35(6): 1270 - 1277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Paradis, N. Dali-Youcef, F. W. Paradis, G. Thibault, and M. Nemer Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling PNAS, January 18, 2000; 97(2): 931 - 936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Nicoletti and J.-B. Michel Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors Cardiovasc Res, March 1, 1999; 41(3): 532 - 543. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Horio, T. Nishikimi, F. Yoshihara, N. Nagaya, H. Matsuo, S. Takishita, and K. Kangawa Production and Secretion of Adrenomedullin in Cultured Rat Cardiac Myocytes and Nonmyocytes: Stimulation by Interleukin-1{beta} and Tumor Necrosis Factor-{alpha} Endocrinology, November 1, 1998; 139(11): 4576 - 4580. [Abstract] [Full Text] [PDF]
|
|